TRT fact-check: Indonesian land rights video misrouted to hormone category

What's this video probably claiming?

This TikTok from @fajartrilaksana.l has nothing to do with testosterone replacement therapy, hormone optimization, or any health topic. The caption is entirely in Indonesian and describes legal advice about how residents can fight a company (PT, or Perseroan Terbatas) that has allegedly included community land within its SHGB (Sertifikat Hak Guna Bangunan, a building-use rights certificate) without the landowners ever voluntarily surrendering their rights. The hashtags confirm this: bantuanhukum (legal aid), belajarhukum (learn law), kemenkumham (Indonesia's Ministry of Law and Human Rights), and ditjenbadilum (Directorate General of General Courts). The creator appears to be a legal practitioner or legal educator offering guidance on property rights disputes, which is a genuinely pressing issue in Indonesia given the frequency of land conflicts between communities and corporate entities. There is no health claim here, stated or implied.

What does the science actually show?

Because this video is a legal education video and not a health or TRT video, there is no biomedical science to evaluate. However, since FormBlends categorized this under TRT, it is worth being clear about what TRT actually involves, so the mismatch is obvious. Testosterone replacement therapy is a clinically studied intervention for male hypogonadism, defined as serum total testosterone below approximately 300 ng/dL with accompanying symptoms. The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend diagnosis only after two morning testosterone measurements. Delivery methods include injections, gels, patches, and pellets, each with distinct pharmacokinetic profiles. None of this is referenced, implied, or adjacent to anything in this TikTok video. The science being evaluated here is Indonesian property law, not endocrinology.

Where does the social media noise diverge from clinical reality?

The divergence here is not between social media health claims and clinical evidence. It is between a content categorization system and actual video content. This video was tagged as TRT content, which is a categorization error. This matters because automated content routing in telehealth platforms can produce real downstream consequences: fact-check articles paired to irrelevant videos waste reader time, erode trust in the platform's editorial process, and potentially bury genuinely important health misinformation that needs scrutiny. In the TRT content space specifically, there is no shortage of actual claims worth examining, including unsupported assertions about testosterone optimizing cognition in eugonadal men (Snyder et al., 2016, NEJM found no cognitive benefit), or claims that pellet dosing is superior to injections (no head-to-head RCT data supports this). Those claims deserve scrutiny. This video does not.

What should you actually know?

Two separate things need addressing here. First, this video should be recategorized. It is Indonesian legal education content about SHGB land title disputes, and it belongs nowhere near the TRT or health content categories. Second, if you landed on this article because you were searching for TRT information, here is what is clinically established: testosterone therapy in men with confirmed hypogonadism improves libido, bone density, and lean mass when serum levels are consistently low (Bhasin et al., 2018). It does not reliably improve mood or cognition in men with normal baseline testosterone (Snyder et al., 2016, NEJM). Risks include erythrocytosis, testicular atrophy, and suppression of spermatogenesis, all of which require clinical monitoring. This fact-check will be updated once the actual video transcript is available, though that update is unlikely to change the core finding: wrong category, no health claims to evaluate.